ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Updates

SUB-TYPE:

Alliance Healthcare UK entered into a new wholesale agreement with Opella Healthcare (T/A Sanofi Consumer Healthcare): February 2024

 

We are pleased to announce that, as of 01 February 2024, Alliance Healthcare UK has become one of the chosen wholesalers to supply Opella Healthcare’s (trading as Sanofi Consumer Healthcare) consumer healthcare products to all pharmacies in the United Kingdom.

 

Opella Healthcare’s consumer healthcare portfolio includes the brands Cialis®Together, Allevia®, Buscopan®Dulcolax® and Phenergan®.

 

Click here for full product details.

SUB-TYPE:

Alliance Healthcare UK to enter into a new solus wholesale agreement with Urgo: February 2024

 

We are pleased to announce that, as of 01 February 2024, Alliance Healthcare UK will become the only wholesaler to supply selected products of Urgo’s advanced woundcare product portfolio to all pharmacies, hospital pharmacies, and doctors in England, Scotland, and Wales. Alliance Healthcare will continue to supply these products in Northern Ireland.

 

Click here for full product details.

SUB-TYPE:

Alliance Healthcare UK to enter into a new solus wholesale agreement with Vitaflo: November 2023

 

We are pleased to announce that, as of 06 November 2023, Alliance Healthcare UK will become the only wholesaler to supply Vitaflo’s product portfolio to all pharmacies, hospitals and doctors in the United Kingdom, including Northern Ireland.

 

Click here for full product details.

SUB-TYPE:

Alliance Healthcare UK to supply NEBIDO in a solus wholesale agreement with Grünenthal: June 2023

 

We are pleased to announce that Alliance Healthcare UK is now the only wholesaler to supply NEBIDO to all pharmacies, hospitals and dispensing doctors in the United Kingdom, including Northern Ireland. NEBIDO has been acquired by Grünenthal from Bayer.

 

Click here for full product details.

SUB-TYPE:

Alliance Healthcare UK to enter into a new wholesale agreement with Neon Healthcare: 1 June 2023

 

We are pleased to announce that, as of 1 June 2023, Alliance Healthcare UK will become one of the chosen wholesalers to supply selected products of Neon Healthcare to all pharmacies, hospitals, and dispensing doctors in the United Kingdom, including Northern Ireland. 

 

Click below for full product details:

 

Neon Healthcare RWA Product List

SUB-TYPE:

Alliance Healthcare UK to enter into a new solus wholesale agreement with

 

EVER Pharma UK Ltd - 2 May 2023

We are pleased to announce that, as of 2 May 2023, Alliance Healthcare UK will become the only wholesaler to supply selected products of EVER Pharma UK to all pharmacies, hospitals, and dispensing doctors in the United Kingdom.

 

Click here for full product details.

SUB-TYPE:

Alliance Healthcare UK to enter into a new solus wholesale agreement with Daiichi Sankyo: 01 May 2023

 

We are pleased to announce that, as of 01 May 2023, Alliance Healthcare UK will become the only wholesaler to supply Daiichi Sankyo’s product portfolio* to all pharmacies, hospitals, and dispensing doctors in the United Kingdom, including Northern Ireland.

 

*ENHERTU will remain in its present distribution arrangement outside of this solus agreement.

 

Click here for full product details.

SUB-TYPE:

Alliance Healthcare UK to supply TRANSTEC in a solus wholesale agreement with Grünenthal: March 2023

 

We are pleased to announce that Alliance Healthcare UK is now the only wholesaler to supply TRANSTEC to all pharmacies, hospitals and dispensing doctors in the United Kingdom, including Northern Ireland. TRANSTEC has been acquired by Grünenthal from Napp Pharmaceuticals.

 

Click here for full product details.

SUB-TYPE:

Zentiva Branded Medical RWA

 

We are pleased to announce that, as of 01 October 2022, Alliance Healthcare UK will become one of the chosen wholesalers to supply Zentiva’s branded medical product portfolio to all pharmacies, hospitals, and dispensing doctors in the United Kingdom.

 

A full list of Zentiva’s branded medical product portfolio is available here.

SUB-TYPE:

CARDENE order blackout period 17-18 May – LXO RWA

 

We are pleased to announce that, as of 19 May 2022, Alliance Healthcare UK will become the only wholesaler to supply CARDENE to all pharmacies, hospitals and dispensing doctors in England, Scotland and Wales. Northern Ireland is not included in this agreement. 


CARDENE has been acquired by Laboratoire XO from Astellas. Following the morning deliveries on Tuesday 17 May Astellas was cease Direct to Pharmacy sales for these products and there will be a transition to a Reduced Wholesaler Model with Laboratoire XO. As a result of this transition there will be a blackout period for customer orders of these products between 17 – 18 May.

 

Final orders for these products will be your standard cut-off time on the evening of Monday 16 May for AM delivery on the Tuesday 17 May. Customers will be able to place orders with Alliance Healthcare for these products from Thursday AM 19 May for delivery from PM 19 May.


From 19 May purchases of these lines will continue to arrive as part of your usual Alliance Healthcare delivery service and, if purchased in isolation, they will not be subject to Alliance Healthcare’s low spend surcharge. To receive these products, you can simply order from Alliance Healthcare in your usual manner. These products will be available on a same day delivery service.


If you would like to discuss these changes in more detail, please do not hesitate to contact your Alliance Healthcare Account Manager.

 

Please see these communications from Alliance Healthcare and Laboratoire XO for more information:

 

Alliance Healthcare - CARDENE customer communication

 

Laboratoire XO -  CARDENE customer communication